Kenya receives 10,700 doses of mpox vaccine

IANS April 10, 2025 218 views

Kenya has received 10,700 mpox vaccine doses to combat the disease's spread across the country. The government collaborated with international health organizations like WHO and UNICEF to secure these critical vaccines. Since the outbreak in July 2024, Kenya has recorded 67 confirmed cases and one death. The comprehensive strategy includes vaccination, border surveillance, contact tracing, and treatment to limit mpox transmission.

"The arrival of the vaccines marks a significant milestone in the national response" - Aden Duale, Health Cabinet Secretary
Nairobi, April 10: Kenya on Thursday received 10,700 doses of mpox vaccines, a boost to its efforts against the spread of the disease.

Key Points

1

Kenya records 67 confirmed mpox cases since July 2024

2

Vaccines acquired through multinational health partnerships

3

Border surveillance and contact tracing implemented

4

WHO provides comprehensive disease transmission information

The government acquired the vaccines in collaboration with the Africa Centres for Disease Control and Prevention, the World Health Organization, UNICEF and Gavi, the vaccine alliance, Aden Duale, cabinet secretary of the Ministry of Health, said in a statement.

"The arrival of the vaccines marks a significant milestone in the national response to interrupt the chain of transmission and limit further spread of the disease," the statement said.

Kenya would use the vaccines alongside other intervention measures, including increased surveillance at 26 border points, contact tracing, and treatment, the minister said.

Since the outbreak of the disease in Kenya in July 2024, the country has recorded 67 confirmed cases and one death, Duale said, Xinhua news agency reported.

Kenya was among nine African countries listed in November last year for allocation of mpox vaccine doses following an increase of cases on the continent.

The others were the Central African Republic, Cote d'Ivoire, the Democratic Republic of the Congo, Liberia, Nigeria, Rwanda, South Africa and Uganda.

According to the WHO, mpox is an infectious disease that can cause a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy. Most people fully recover, but some get very sick, Xinhua news agency reported.

Mpox spreads from person to person mainly through close contact with someone who has mpox, including members of a household. Close contact includes skin-to-skin and mouth-to-mouth or mouth-to-skin contact, and it can also include being face-to-face with someone who has mpox (such as talking or breathing close to one another, which can generate infectious respiratory particles).

Mpox causes signs and symptoms which usually begin within a week but can start 1-21 days after exposure. Symptoms typically last 2-4 weeks but may last longer in someone with a weakened immune system.

For some people, the first symptom of mpox is a rash, while others may have a fever, muscle aches, or sore throat first.

The mpox rash often begins on the face and spreads over the body, extending to the palms of the hands and soles of the feet. It can also start on other parts of the body where contact is made, such as the genitals. It starts as a flat sore, which develops into a blister filled with liquid that may be itchy or painful. As the rash heals, the lesions dry up, crust over, and fall off.

Reader Comments

J
James K.
This is great news for Kenya! The collaboration between multiple health organizations shows how we can tackle diseases when we work together. Hope the vaccines reach those who need them most. 🙏
A
Amina W.
Only 10,700 doses for the whole country? That seems very low considering we've had 67 cases already. I appreciate the effort but hope more vaccines are coming soon.
P
Peter M.
The border surveillance is just as important as the vaccines. Mpox doesn't respect borders, so we need to be vigilant at all entry points. Good to see a multi-pronged approach!
N
Naomi S.
I wish the article explained more about who will get priority for these vaccines. Healthcare workers? High-risk communities? Transparency in distribution will be key to public trust.
D
David L.
The symptoms sound awful! 😣 Glad Kenya is taking action. The detailed explanation about transmission was really helpful - more people need to understand how it spreads to protect themselves.
S
Sarah T.
While I appreciate the vaccine rollout, I hope there's equal focus on public education. Many people in rural areas might not recognize the symptoms early enough to seek help.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Your email won't be published

Tags:
You May Like!